Evidence map›Paper›PMID 35354790›Full record

ArticleNature communications2022

Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids.

Suran Kim, Sungjin Min, Yi Sun Choi, Sung-Hyun Jo, Jae Hun Jung, Kyusun Han, Jin Kim, Soohwan An, Yong Woo Ji, Yun-Gon Kim and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 226 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
226citing papers in PubMed, 3 pooled it
65.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

226 citing papers in PubMed, 3 syntheses or guidelines pooled it, 320 citations in OpenAlex.

  1. [Organoid-based strategies and challenges in tissue regeneration].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Recent advancements and limitations of intestinal organoids for clinical applications.Progress in biomedical engineering (Bristol, England) · 2026
    Review
  19. Review
  20. Article

166 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Suran Kim *Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Sungjin Min *Department of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Yi Sun ChoiDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0002-4691-8875
Sung-Hyun JoDepartment of Chemical Engineering, Soongsil University, Seoul, 06978, Republic of Korea.ORCID http://orcid.org/0000-0002-2854-1568
Jae Hun JungInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, 06229, Republic of Korea.
Kyusun HanInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, 06229, Republic of Korea.
Jin KimDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0002-7667-9588
Soohwan AnDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
Yong Woo JiInstitute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, 06229, Republic of Korea.ORCID http://orcid.org/0000-0002-7211-6278
Yun-Gon KimDepartment of Chemical Engineering, Soongsil University, Seoul, 06978, Republic of Korea.
Seung-Woo ChoDepartment of Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. seungwoocho@yonsei.ac.kr.ORCID http://orcid.org/0000-0001-8058-332X
Yonsei University · KRSoongsil University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrigel, a mouse tumor extracellular matrix protein mixture, is an indispensable component of most organoid tissue culture. However, it has limited the utility of organoids for drug development and regenerative medicine due to its tumor-derived origin, batch-to-batch variation, high cost, and safety issues. Here, we demonstrate that gastrointestinal tissue-derived extracellular matrix hydrogels are suitable substitutes for Matrigel in gastrointestinal organoid culture. We found that the development and function of gastric or intestinal organoids grown in tissue extracellular matrix hydrogels are comparable or often superior to those in Matrigel. In addition, gastrointestinal extracellular matrix hydrogels enabled long-term subculture and transplantation of organoids by providing gastrointestinal tissue-mimetic microenvironments. Tissue-specific and age-related extracellular matrix profiles that affect organoid development were also elucidated through proteomic analysis. Together, our results suggest that extracellular matrix hydrogels derived from decellularized gastrointestinal tissues are effective alternatives to the current gold standard, Matrigel, and produce organoids suitable for gastrointestinal disease modeling, drug development, and tissue regeneration.

Indexed as

HydrogelsOrganoidsAnimalsCollagenDrug CombinationsExtracellular MatrixLamininMiceProteoglycansProteomicsCollagenDrug CombinationsHydrogelsLamininmatrigelProteoglycans

Identifiers

PMID35354790
PMCPMC8967832
OpenAlexW4220834703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.